Compare $ABVC vs $BYSI | Chartloom

Compare

$ABVC vs $BYSI

ABVC Biopharma Inc · Beyondspring Inc

ABVC

ABVC Biopharma Inc

BYSI

Beyondspring Inc

Compare $ABVC vs $BYSI

Comparing ABVC Biopharma Inc and Beyondspring Inc

ABVCABVC Biopharma Inc

BYSIBeyondspring Inc

ABVCABVC Biopharma Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-54.3%

52W performance

-69.1%

FCF yield

-10.4%

BYSIBeyondspring Inc

Market cap

$25M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-62.4%

52W performance

-66.2%

FCF yield

-67.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABVC

BYSI

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

BYSI

Beyondspring Inc

Market Cap

ABVC$26M

BYSI$25M

Enterprise Value

ABVC$27M

BYSI$22M

Price

ABVC$1.00

BYSI$0.61

P/E Ratio

ABVCN/A

BYSIN/A

P/S Ratio

ABVC39.44x

BYSI23.96x

EV/Sales

ABVC40.47x

BYSI21.97x

EV/EBITDA

ABVC0.00x

BYSI0.00x

P/B Ratio

ABVC3.06x

BYSI3.99x

P/FCF Ratio

ABVCN/A

BYSIN/A

EV/FCF

ABVC-9.95x

BYSI-1.33x

PEG Ratio

ABVCN/A

BYSIN/A

Forward P/E (NTM)

ABVCN/A

BYSIN/A

Forward P/S (NTM)

ABVCN/A

BYSIN/A

Revenue (TTM)

ABVC$0

BYSI$0

Revenue Growth (YoY)

ABVC-100.0%

BYSIN/A

Forward Rev Growth

ABVC0.0%

BYSI0.0%

Gross Margin (TTM)

ABVC0.3%

BYSI0.0%

Operating Margin (TTM)

ABVC0.0%

BYSI0.0%

EBITDA Margin (TTM)

ABVC0.0%

BYSI0.0%

Net Margin (TTM)

ABVC0.0%

BYSI0.0%

FCF Margin (TTM)

ABVCN/A

BYSIN/A

Net Income (TTM)

ABVC$-8M

BYSI$-7M

FCF (TTM)

ABVC$-3M

BYSI$-17M

EPS (TTM)

ABVC-$0.30

BYSI-$0.16

ROE (TTM)

ABVC-7147.0%

BYSI-13313.0%

ROA (TTM)

ABVC-3883.0%

BYSI-3024.0%

ROIC (TTM)

ABVC-6509.0%

BYSI-12817.0%

Cash

ABVC$32K

BYSI$3M

Debt

ABVC$859K

BYSI$0

Net Cash/Debt

ABVC$-827K

BYSI$3M

Current Ratio (TTM)

ABVC0.07x

BYSI0.70x

Quick Ratio (TTM)

ABVC0.05x

BYSI0.66x

Debt/Equity (TTM)

ABVC0.08x

BYSI0.06x

Debt/Assets (TTM)

ABVC0.0%

BYSI0.0%

Interest Coverage (TTM)

ABVCN/A

BYSIN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

BYSI0.00x

Beta

ABVC0.50

BYSI-0.26

52W Performance

ABVC-69.1%

BYSI-66.2%

YTD Performance

ABVC-54.3%

BYSI-62.4%

% from 52W High

ABVC-70.0%

BYSI-75.2%

% from 52W Low

ABVC40.8%

BYSI7.1%

Asset Turnover (TTM)

ABVC0.06x

BYSI0.02x

FCF Yield (TTM)

ABVC-10.4%

BYSI-67.2%

Earnings Yield (TTM)

ABVC-30.4%

BYSI-26.8%

Dividend Yield (TTM)

ABVCN/A

BYSIN/A

Rule of 40

ABVC-100.0

BYSI0.0

EV/GP/RG

ABVCN/A

BYSIN/A

Ticker research

View ABVC research View BYSI research

Metric	ABVC ABVC Biopharma Inc	BYSI Beyondspring Inc
Market & Valuation
Market Cap	$26M	$25M
Enterprise Value	$27M	$22M
Price	$1.00	$0.61
P/E Ratio	N/A	N/A
P/S Ratio	39.44x	23.96x
EV/Sales	40.47x	21.97x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.06x	3.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.95x	-1.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-7M
FCF (TTM)	$-3M	$-17M
EPS (TTM)	-$0.30	-$0.16
ROE (TTM)	-7147.0%	-13313.0%
ROA (TTM)	-3883.0%	-3024.0%
ROIC (TTM)	-6509.0%	-12817.0%
Financial Health
Cash	$32K	$3M
Debt	$859K	$0
Net Cash/Debt	$-827K	$3M
Current Ratio (TTM)	0.07x	0.70x
Quick Ratio (TTM)	0.05x	0.66x
Debt/Equity (TTM)	0.08x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	-0.26
52W Performance	-69.1%	-66.2%
YTD Performance	-54.3%	-62.4%
% from 52W High	-70.0%	-75.2%
% from 52W Low	40.8%	7.1%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.02x
FCF Yield (TTM)	-10.4%	-67.2%
Earnings Yield (TTM)	-30.4%	-26.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View BYSI research

Valuation

P/S Ratio

BYSI

23.96x

ABVC

39.44x

EV/FCF

ABVC

-9.95x

BYSI

-1.33x

Growth & revenue

Revenue Growth TTM

ABVC

-100.0%

Forward Revenue Growth

ABVC

0.0%

BYSI

0.0%

Profitability & performance

Gross Margin

ABVC

0.3%

BYSI

0.0%

ROE

ABVC

-7147.0%

BYSI

-13313.0%

FCF Yield %

ABVC

-10.4%

BYSI

-67.2%

52-Week Performance

BYSI

-66.2%

ABVC

-69.1%

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

BYSI

Beyondspring Inc

Market Cap

ABVC$26M

BYSI$25M

Enterprise Value

ABVC$27M

BYSI$22M

Price

ABVC$1.00

BYSI$0.61

P/E Ratio

ABVCN/A

BYSIN/A

P/S Ratio

ABVC39.44x

BYSI23.96x

EV/Sales

ABVC40.47x

BYSI21.97x

EV/EBITDA

ABVC0.00x

BYSI0.00x

P/B Ratio

ABVC3.06x

BYSI3.99x

P/FCF Ratio

ABVCN/A

BYSIN/A

EV/FCF

ABVC-9.95x

BYSI-1.33x

PEG Ratio

ABVCN/A

BYSIN/A

Forward P/E (NTM)

ABVCN/A

BYSIN/A

Forward P/S (NTM)

ABVCN/A

BYSIN/A

Revenue (TTM)

ABVC$0

BYSI$0

Revenue Growth (YoY)

ABVC-100.0%

BYSIN/A

Forward Rev Growth

ABVC0.0%

BYSI0.0%

Gross Margin (TTM)

ABVC0.3%

BYSI0.0%

Operating Margin (TTM)

ABVC0.0%

BYSI0.0%

EBITDA Margin (TTM)

ABVC0.0%

BYSI0.0%

Net Margin (TTM)

ABVC0.0%

BYSI0.0%

FCF Margin (TTM)

ABVCN/A

BYSIN/A

Net Income (TTM)

ABVC$-8M

BYSI$-7M

FCF (TTM)

ABVC$-3M

BYSI$-17M

EPS (TTM)

ABVC-$0.30

BYSI-$0.16

ROE (TTM)

ABVC-7147.0%

BYSI-13313.0%

ROA (TTM)

ABVC-3883.0%

BYSI-3024.0%

ROIC (TTM)

ABVC-6509.0%

BYSI-12817.0%

Cash

ABVC$32K

BYSI$3M

Debt

ABVC$859K

BYSI$0

Net Cash/Debt

ABVC$-827K

BYSI$3M

Current Ratio (TTM)

ABVC0.07x

BYSI0.70x

Quick Ratio (TTM)

ABVC0.05x

BYSI0.66x

Debt/Equity (TTM)

ABVC0.08x

BYSI0.06x

Debt/Assets (TTM)

ABVC0.0%

BYSI0.0%

Interest Coverage (TTM)

ABVCN/A

BYSIN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

BYSI0.00x

Beta

ABVC0.50

BYSI-0.26

52W Performance

ABVC-69.1%

BYSI-66.2%

YTD Performance

ABVC-54.3%

BYSI-62.4%

% from 52W High

ABVC-70.0%

BYSI-75.2%

% from 52W Low

ABVC40.8%

BYSI7.1%

Asset Turnover (TTM)

ABVC0.06x

BYSI0.02x

FCF Yield (TTM)

ABVC-10.4%

BYSI-67.2%

Earnings Yield (TTM)

ABVC-30.4%

BYSI-26.8%

Dividend Yield (TTM)

ABVCN/A

BYSIN/A

Rule of 40

ABVC-100.0

BYSI0.0

EV/GP/RG

ABVCN/A

BYSIN/A

Ticker research

View ABVC research View BYSI research

Metric	ABVC ABVC Biopharma Inc	BYSI Beyondspring Inc
Market & Valuation
Market Cap	$26M	$25M
Enterprise Value	$27M	$22M
Price	$1.00	$0.61
P/E Ratio	N/A	N/A
P/S Ratio	39.44x	23.96x
EV/Sales	40.47x	21.97x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.06x	3.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.95x	-1.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-7M
FCF (TTM)	$-3M	$-17M
EPS (TTM)	-$0.30	-$0.16
ROE (TTM)	-7147.0%	-13313.0%
ROA (TTM)	-3883.0%	-3024.0%
ROIC (TTM)	-6509.0%	-12817.0%
Financial Health
Cash	$32K	$3M
Debt	$859K	$0
Net Cash/Debt	$-827K	$3M
Current Ratio (TTM)	0.07x	0.70x
Quick Ratio (TTM)	0.05x	0.66x
Debt/Equity (TTM)	0.08x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	-0.26
52W Performance	-69.1%	-66.2%
YTD Performance	-54.3%	-62.4%
% from 52W High	-70.0%	-75.2%
% from 52W Low	40.8%	7.1%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.02x
FCF Yield (TTM)	-10.4%	-67.2%
Earnings Yield (TTM)	-30.4%	-26.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View BYSI research